Phase
Condition
Sleep Disorders
Parkinson's Disease
Insomnia
Treatment
Deep Brain Stimulation
Clinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Signed informed consent
Diagnosis of Idiopathic Parkinson's disease (PD) with motor symptoms present for aminimum of 4 years
Severe motor symptoms (e.g., motor fluctuations, dyskinesia, tremor, bradykinesia,rigidity) despite optimized medical therapy, that warrant surgical implantation ofdeep brain stimulation (DBS), according to standard clinical criteria
Unified Parkinson's Disease Rating Scale (UPDRS-III) score off medication 20 to 80,and improvement of at least 30% in UPDRS-III score on medications, ortremor-dominant PD (score >/= 2 on UPDRS-III tremor sub-score) or tremor in additionto other motor symptoms that are treatment-resistant and result in significantfunctional disability
Appropriate trials of oral PD medications resulting in inadequate relief of motorsymptoms as determined by a movement disorders neurologist, and stable dose ofanti-PD medications for 30 days prior to study enrollment
Requested and approved for subthalamic nucleus deep brain stimulation surgery (STNDBS) by study site Multi-Disciplinary Movement Disorders Patient Care Conference
Absence of abnormalities on brain magnetic resonance imaging (MRI) scan suggestiveof an alternate diagnosis or serving as a contraindication to surgery
Absence of significant cognitive deficits or significant depression (Beck DepressionInventory-II, BDI-II, score > 20) on formal Neuropsychological Testing
Age 18 to 80 years (19 to 80 years in Nebraska)
Able to conduct follow up neurological care exclusively at study site for durationof the RC+S INS neurostimulator device lifespan (9 years)
Exclusion
Exclusion Criteria:
Any medical condition considered to elevate risk for surgical complications, such ascoagulopathy,, uncontrolled hypertension, history of seizures, heart disease,inability to undergo general anesthesia, or anticoagulant medications that cannot besafely discontinued for perioperative period
Pregnancy (women of child-bearing potential must have a negative urine pregnancytest prior to surgical procedures)
Significant untreated depression (Beck Depression Inventory-II, BDI-II > 20 orGeriatric Depression Scale, GDS, score > 8)
Personality or mood disorder symptoms that investigators believe will interfere withstudy requirements
Required ongoing treatment with electroconvulsive therapy (ECT), repetitivetranscranial magnetic stimulation (rTMS), or diathermy
Pre-existing implanted stimulation system (e.g., cochlear implant, cardiacpacemaker, defibrillator, neuro-stimulator for indication other than Parkinson'sdisease), or ferromagnetic metallic implant
Prior intracranial surgery
History or active, drug or alcohol abuse
Meets criteria for Parkinson's disease (PD) with Mild Cognitive Impairment (PD-MCI),as defined by Performance > 2 standard deviations below appropriate norms on testsfrom 2 or more of the following cognitive domains: Attention, Executive Function,Language, Memory, and Visuospatial Ability
Restless Leg Syndrome
Obstructive Sleep Apnea
Inability to perform the recharge process necessary to use the RC+S brainstimulation system
Study Design
Study Description
Connect with a study center
Standord University Medical Center
Stanford, California 94305
United StatesSite Not Available
University of Colorado Denver School of Medicine
Aurora, Colorado 80045
United StatesSite Not Available
University of Nebraska Medical Center
Omaha, Nebraska 68198
United StatesActive - Recruiting
University of Pennsylvania Health System
Philadelphia, Pennsylvania 19106
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.